Universitätsklinikum Münster

High adherence to angiotensin-converting enzyme inhibitor in children and adolescents with Alport syndrome: objective verification using liquid chromatography-mass spectrometry (2025) Boeckhaus J, Tönshoff B, Weber LT, Haffner D, Pape L, Latta K, Fehrenbach H, et al. Journal article Head-to-head comparison of TKI and CPI first-line treatment strategies in advanced renal cell carcinoma—Real-world data from the German research platform CARAT (2025) Goebell P, Bögemann M, Nusch A, Grünwald V, Müller L, von der Heyde E, Martens UM, et al. Journal article Early Treatment With Intravenous Immunoglobulins and Outcomes of Patients With Anti-IgLON5 Disease. (2025) Grüter T, Gaig C, Crijnen YS, Titulaer MJ, Sabater L, Heidbreder A, Dargvainiene J, et al. Journal article Disease risk but not remission status determines transplant outcomes in AML: long-term outcomes of the ASAP trial (2025) Stelljes M, Middeke JM, Bug G, Wagner-Drouet EM, Müller LP, Schmid C, Krause S, et al. Journal article Modern approaches to radiotherapy in primary cutaneous lymphomas: insights and recommendations from the DEGRO dermato-oncology working group (2025) Elsayad K, Correia D, Theiß U, Baehr A, Besserer A, Micke O, Greve B, et al. Journal article Aquagenic Pruritus Questionnaire: Predicting Myeloproliferative Neoplasms in Patients with Aquagenic Pruritus (2025) Witte F, Weisshaar E, Metz M, Koschmieder S, Isfort S, Kremer A, Griesshammer M, et al. Journal article Preserve interdisciplinary emergency medicine!: Commentary on the suggested curriculum for a “specialist in emergency medicine” Interdisziplinäre Notfallmedizin erhalten!: Kommentar zum vorgeschlagenen Curriculum für einen „Facharzt für Notfallmedizin“ (2025) Josuttis D, Becker C, Beuker C, Jahnke L, Kerth JL, Lieftüchter V, Meyer I, et al. Journal article Impact of bleeding and thrombosis on outcome of 945 COVID-19 VV-ECMO cases from a German registry (2025) Herrmann J, Schade J, Meybohm P, Paschke N, Hübsch ME, Notz Q, Groene J, et al. Journal article Gemtuzumab ozogamicin in first-line treatment of CBF-AML: insights from a retrospective multi-center analysis (2025) Ronnacker J, Muller PJ, Mikesch JH, Zukunft S, Weinbergerová B, Šrámek J, Valka J, et al. Journal article Efficacy and Safety of Nemolizumab in Patients With Moderate to Severe Prurigo Nodularis: The OLYMPIA 1 Randomized Clinical Phase 3 Trial. (2025) Ständer S, Yosipovitch G, Legat FJ, Reich A, Paul C, Simon D, Naldi L, et al. Journal article